Atomi Financial Group’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$683K Sell
1,290
-142
-10% -$65.5K 0.02% 639
2026
Q1
$688K Buy
1,432
+108
+8% +$55.3K 0.02% 576
2025
Q4
$744K Buy
1,324
+21
+2% +$11.9K 0.02% 524
2025
Q3
$670K Buy
1,303
+128
+11% +$55.9K 0.02% 525
2025
Q2
$369K Sell
1,175
-55
-4% -$16.5K 0.01% 717
2025
Q1
$375K Buy
1,230
+164
+15% +$55.2K 0.02% 666
2024
Q4
$354K Buy
+1,066
New +$362K 0.02% 637

Other funds holding MEDP

Atomi Financial Group's MEDP Position: Q2 2026 in Review

Atomi Financial Group reduced its Medpace (MEDP) stake by 9.9% in Q2 2026, selling an estimated $65.5K and leaving 1,290 shares worth $683K. The position accounts for 0.02% of the portfolio, ranked #639.

Atomi Financial Group first reported a position in MEDP in Q4 2024 and has held it in 7 quarters since. The position peaked at $744K in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Atomi Financial Group held 1,290 shares of Medpace worth $683K as of Q2 2026.
  • Atomi Financial Group sold 142 Medpace shares in Q2 2026, an estimated $65.5K.
  • Medpace made up 0.02% of Atomi Financial Group's portfolio in Q2 2026, its #639 holding.
  • Atomi Financial Group first reported a position in Medpace in Q4 2024 and has held it in 7 quarters since.
  • Atomi Financial Group's Medpace position peaked at $744K in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Atomi Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.